Purchases and Sales Made in Q4 2021 in Intellia Therapeutics, Inc. (NTLA)
This table provides information about the institutional ownership of Intellia Therapeutics, Inc. (NTLA) during Q4 2021. The information is specifically focused on institutions that hold shares of Intellia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-194K- 28.87% |
$19.5M - $26.8M
|
477K
$4.54M
|
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-244K- 10.42% |
$24.6M - $33.8M
|
2.1M
$20M
|
|
|
Feb 14, 2022
Q4 2021
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-251KClosed |
$25.3M - $34.7M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Temasek Holdings (Private) LTD
Singapore, U0 |
SELL
|
- |
-398K- 66.06% |
$40.1M - $55M
|
204K
$1.94M
|